Institutional Research and Academic Career Development Award CAREER Program Opportunity

Funded by the NIH/NIGMS K12 Institutional Research and Academic Career Development Award (IRACDA) mechanism, the Chicago ARea Excellence in Education & Research (CAREER) program is a 3+ year mentored fellowship designed to provide rigorous and balanced team-based training in research and teaching to postdoctoral fellows. The goal of UIC CAREER is to build a culturally diverse group of fellows who, upon completing the program, are well equipped to be leaders in academia at…

Continue Reading

Wellness House programs flourish despite COVID-19 pandemic

Looking through a brochure at her doctor’s office, Araceli read with great interest the offerings Wellness House provides cancer patients such as herself: exercise and nutrition courses, stress management lessons, and support groups and counseling, among others. The medication she was taking to combat breast cancer often left her lethargic, unusual for someone who was so active and physically fit. The programs, she believed, could help her regain the vitality she was used…

Continue Reading

Patel named different kind of ‘Rockstar’

He may not be a rock star on stage, but the University of Illinois College of Medicine considers Pritesh Patel one with his patients.The Department of Medicine annually recognizes one faculty member from each division as a “Divisional Rockstar” for their contributions to the department. Patel, MD, associate director of the Blood & Marrow Transplant (BMT) program in the division of hematology and oncology and member of the UI Cancer Center’s Translational Oncology…

Continue Reading

Gadi joining ACS panel discussing immunotherapy and cancer care

The rise in immunotherapy cancer treatments are a major factor why cancer mortality rates have experienced a 30% drop since 1991, according to the American Cancer Society’s Cancer Facts and Figures reports.V.K. Gadi, MD, PhD, associate director for Translational Oncology Medicine at the UI Cancer Center, will be a panelist discussing how immunotherapy is revolutionizing cancer care and how it influences a patient’s experience. The free Zoom event, sponsored by the American Cancer Society’s…

Continue Reading

Jain answers questions about COVID-19

Shikha Jain, MD, FACP, assistant professor of hematology/oncology at the College of Medicine, Director of Communication Strategies in Medicine, and Associate Director of Oncology Communication & Digital Innovation, returned to Fox Channel 32’s Good Day Chicago last week to answer commonly asked questions about coronavirus testing. View here

Continue Reading

MSU’s Breslin Cancer Center hosting Big Ten CRC Grand Rounds

“Deciphering Metabolic Reprogamming in Metastasis” is the topic of September’s Big Ten Cancer Research Consortium’s Grand Rounds. The Zoom event, hosted by Michigan State University Breslin Cancer Center, will be held on Thursday, Sept. 10, at 11:30 a.m. Presenters will be Sophia Lunt, PhD, assistant professor of biochemistry and molecular biology in Michigan State’s department of chemical engineering and materials science, and Daniel Isaac, DO, MS, assistant professor of medicine, division of hematology/oncology,…

Continue Reading

Reprogramming immune cells to reduce inflammation, promote tissue repair

In a new study published in the journal Nature Immunology, University of Illinois at Chicago researchers led by University of Illinois Cancer Center member Asrar Malik, PhD, suggests that macrophage programming is more difficult than originally believed. Macrophages are white blood cells that, depending on the signals they get from the immune system, become specialized in either increasing or decreasing inflammation. When macrophages are programmed to be pro-inflammatory, they help to increase inflammation, which…

Continue Reading

Stewart and Watson featured on NBC Chicago

“Screening saves lives.” That was the message UI Cancer Center members John Stewart IV, MD, MBA, FACS, associate director of clinical research, and Karriem Watson, DHSc, MS, MPH, associate director of community outreach and engagement and director of community based research at Mile Square Health Center, told WMAQ Ch. 5 viewers during an interview about young adults undergoing colon cancer screening. View here

Continue Reading

Phase 1 human trials suggest UIC-developed breast cancer drug is safe, effective

A new type of breast cancer drug developed by University of Illinois Cancer Center members Debra Tonetti and Gregory Thatcher can help halt progression of disease and is not toxic, according to phase 1 clinical trials. The drug is specifically designed for women whose cancer has stopped responding to hormone therapy. The results are published in the journal Breast Cancer Research and Treatment. Breast cancer affects one in eight women in the United…

Continue Reading